Beschreibung
In vitro and in vivo evaluation strategies for assessing the efficacy of anti-hair loss cosmeceutical formulations.
Fig. 12
DiagramSource Paper
Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation.Cite This Figure
 > Source: Xuexue Pan et al. "Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mecha." *Aesthetic plastic surgery*, 2025. PMID: [40790388](https://pubmed.ncbi.nlm.nih.gov/40790388/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594698/bin/266_2025_5077_Fig12_HTML.jpg" alt="In vitro and in vivo evaluation strategies for assessing the efficacy of anti-hair loss cosmeceutical formulations." /> <figcaption>Fig. 12. In vitro and in vivo evaluation strategies for assessing the efficacy of anti-hair loss cosmeceutical formulations.<br> Source: Xuexue Pan et al. "Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mecha." <em>Aesthetic plastic surgery</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40790388/">40790388</a></figcaption> </figure>
Verwandte Evidenz
A
Finasterid für Androgenetische Alopezie
A
Bewertung A · 206 Studien
Minoxidil für Alopecia Areata
A
Bewertung A · 122 Studien
Minoxidil für Telogen Effluvium
A
Bewertung A · 66 Studien
Minoxidil für Androgenetische Alopezie
A
Bewertung A · 299 Studien
Microneedling für Alopecia Areata
A
Bewertung A · 34 Studien
Microneedling für Androgenetische Alopezie
B
Bewertung A · 62 Studien
Eisen für Telogen Effluvium
Bewertung B · 62 Studien